Serine and arginine rich splicing factor 1: a potential target for neuroprotection and other diseases.

Sandoval-Castellanos, Ana M; Bhargava, Anushka; Zhao, Min; Xu, Jun; Ning, Ke

Sandoval-Castellanos, Ana M; Bhargava, Anushka; Zhao, Min; Xu, Jun; Ning, Ke.

Afiliação

Sandoval-Castellanos AM; Sheffield Institute of Translational Neuroscience, SITraN, The University of Sheffield, Sheffield, UK; Department of Ophthalmology & Vision Science, and Department of Dermatology, Institute for Regenerative Cures, University of California at Davis, School of Medicine, Sacramento, CA, USA.
Bhargava A; Sheffield Institute of Translational Neuroscience, SITraN, The University of Sheffield, Sheffield, UK.
Zhao M; Department of Ophthalmology & Vision Science, and Department of Dermatology, Institute for Regenerative Cures, University of California at Davis, School of Medicine, Sacramento, CA, USA.
Xu J; East Hospital, Tongji University School of Medicine, Shanghai, China.
Ning K; Sheffield Institute of Translational Neuroscience, SITraN, The University of Sheffield, Sheffield, UK; East Hospital, Tongji University School of Medicine, Shanghai, China.

Neural Regen Res ; 18(7): 1411-1416, 2023 Jul.

Article em En | MEDLINE | ID: mdl-36571335

Palavras-chave

SRSF1; alternative splicing; autoimmune disorders; cancer; hypertension; mRNA; neuroprotection; splicing factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Neural Regen Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google